MAPT and Alzheimer disease: Microglial activation is thought to be a double‐edged sword in AD, as activated microglia can phagocytose Aβ and tau and prevent proteopathy, whereas excessive inflammatory activation can accelerate plaque accumulation and synapse loss (Lananna et al., 2020).